Supplementing healthy women with up to 5.0 g/d of L-tryptophan has no adverse effects. Hiratsuka, C., Fukuwatari, T., Sano, M., Saito, K., Sasaki, S., & Shibata, K. The Journal of Nutrition, 143(6):859–866, June, 2013. doi abstract bibtex Because of the frequent use of L-tryptophan (L-Trp) in dietary supplements, determination of the no-observed-adverse-effect-level is desirable for public health purposes. We therefore assessed the no-observed-adverse-effect-level for L-Trp and attempted to identify a surrogate biomarker for excess L-Trp in healthy humans. A randomized, double-blind, placebo-controlled, crossover intervention study was performed in 17 apparently healthy Japanese women aged 18-26 y with a BMI of ≈ 20 kg/m(2). The participants were randomly assigned to receive placebo (0 g/d) or 1.0, 2.0, 3.0, 4.0, or 5.0 g/d of L-Trp for 21 d each with a 5-wk washout period between trials. Food intake, body weight, general biomarkers in blood and urine, and amino acid composition in blood and urine were not affected by any dose of L-Trp. Administration of up to 5.0 g/d L-Trp had no effect on a profile of mood states category measurement. The urinary excretion of nicotinamide and its catabolites increased in proportion to the ingested amounts of L-Trp, indicating that participants could normally metabolize this amino acid. The urinary excretion of L-tryptophan metabolites, including kynurenine (Kyn), anthranilic acid, kynurenic acid, 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid, and quinolinic acid (QA), all of which are intermediates of the L-TRP→Kyn→QA pathway, was in proportion to L-Trp loading. The response of 3-HK was the most characteristic of these L-Trp metabolites. This finding suggests that the urinary excretion of 3-HK is a good surrogate biomarker for excess L-Trp ingestion.
@article{hiratsuka_supplementing_2013,
title = {Supplementing healthy women with up to 5.0 g/d of {L}-tryptophan has no adverse effects},
volume = {143},
issn = {1541-6100},
doi = {10.3945/jn.112.173823},
abstract = {Because of the frequent use of L-tryptophan (L-Trp) in dietary supplements, determination of the no-observed-adverse-effect-level is desirable for public health purposes. We therefore assessed the no-observed-adverse-effect-level for L-Trp and attempted to identify a surrogate biomarker for excess L-Trp in healthy humans. A randomized, double-blind, placebo-controlled, crossover intervention study was performed in 17 apparently healthy Japanese women aged 18-26 y with a BMI of ≈ 20 kg/m(2). The participants were randomly assigned to receive placebo (0 g/d) or 1.0, 2.0, 3.0, 4.0, or 5.0 g/d of L-Trp for 21 d each with a 5-wk washout period between trials. Food intake, body weight, general biomarkers in blood and urine, and amino acid composition in blood and urine were not affected by any dose of L-Trp. Administration of up to 5.0 g/d L-Trp had no effect on a profile of mood states category measurement. The urinary excretion of nicotinamide and its catabolites increased in proportion to the ingested amounts of L-Trp, indicating that participants could normally metabolize this amino acid. The urinary excretion of L-tryptophan metabolites, including kynurenine (Kyn), anthranilic acid, kynurenic acid, 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid, and quinolinic acid (QA), all of which are intermediates of the L-TRP→Kyn→QA pathway, was in proportion to L-Trp loading. The response of 3-HK was the most characteristic of these L-Trp metabolites. This finding suggests that the urinary excretion of 3-HK is a good surrogate biomarker for excess L-Trp ingestion.},
language = {eng},
number = {6},
journal = {The Journal of Nutrition},
author = {Hiratsuka, Chiaki and Fukuwatari, Tsutomu and Sano, Mitsue and Saito, Kuniaki and Sasaki, Satoshi and Shibata, Katsumi},
month = jun,
year = {2013},
pmid = {23616514},
keywords = {Adolescent, Adult, Biomarkers, Body Mass Index, Cross-Over Studies, Dietary Supplements, Double-Blind Method, Female, Humans, Kynurenic Acid, Kynurenine, Niacinamide, Placebos, Tryptophan, Young Adult, ortho-Aminobenzoates},
pages = {859--866},
}
Downloads: 0
{"_id":"5Ngmay4tpr5QudCiR","bibbaseid":"hiratsuka-fukuwatari-sano-saito-sasaki-shibata-supplementinghealthywomenwithupto50gdofltryptophanhasnoadverseeffects-2013","author_short":["Hiratsuka, C.","Fukuwatari, T.","Sano, M.","Saito, K.","Sasaki, S.","Shibata, K."],"bibdata":{"bibtype":"article","type":"article","title":"Supplementing healthy women with up to 5.0 g/d of L-tryptophan has no adverse effects","volume":"143","issn":"1541-6100","doi":"10.3945/jn.112.173823","abstract":"Because of the frequent use of L-tryptophan (L-Trp) in dietary supplements, determination of the no-observed-adverse-effect-level is desirable for public health purposes. We therefore assessed the no-observed-adverse-effect-level for L-Trp and attempted to identify a surrogate biomarker for excess L-Trp in healthy humans. A randomized, double-blind, placebo-controlled, crossover intervention study was performed in 17 apparently healthy Japanese women aged 18-26 y with a BMI of ≈ 20 kg/m(2). The participants were randomly assigned to receive placebo (0 g/d) or 1.0, 2.0, 3.0, 4.0, or 5.0 g/d of L-Trp for 21 d each with a 5-wk washout period between trials. Food intake, body weight, general biomarkers in blood and urine, and amino acid composition in blood and urine were not affected by any dose of L-Trp. Administration of up to 5.0 g/d L-Trp had no effect on a profile of mood states category measurement. The urinary excretion of nicotinamide and its catabolites increased in proportion to the ingested amounts of L-Trp, indicating that participants could normally metabolize this amino acid. The urinary excretion of L-tryptophan metabolites, including kynurenine (Kyn), anthranilic acid, kynurenic acid, 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid, and quinolinic acid (QA), all of which are intermediates of the L-TRP→Kyn→QA pathway, was in proportion to L-Trp loading. The response of 3-HK was the most characteristic of these L-Trp metabolites. This finding suggests that the urinary excretion of 3-HK is a good surrogate biomarker for excess L-Trp ingestion.","language":"eng","number":"6","journal":"The Journal of Nutrition","author":[{"propositions":[],"lastnames":["Hiratsuka"],"firstnames":["Chiaki"],"suffixes":[]},{"propositions":[],"lastnames":["Fukuwatari"],"firstnames":["Tsutomu"],"suffixes":[]},{"propositions":[],"lastnames":["Sano"],"firstnames":["Mitsue"],"suffixes":[]},{"propositions":[],"lastnames":["Saito"],"firstnames":["Kuniaki"],"suffixes":[]},{"propositions":[],"lastnames":["Sasaki"],"firstnames":["Satoshi"],"suffixes":[]},{"propositions":[],"lastnames":["Shibata"],"firstnames":["Katsumi"],"suffixes":[]}],"month":"June","year":"2013","pmid":"23616514","keywords":"Adolescent, Adult, Biomarkers, Body Mass Index, Cross-Over Studies, Dietary Supplements, Double-Blind Method, Female, Humans, Kynurenic Acid, Kynurenine, Niacinamide, Placebos, Tryptophan, Young Adult, ortho-Aminobenzoates","pages":"859–866","bibtex":"@article{hiratsuka_supplementing_2013,\n\ttitle = {Supplementing healthy women with up to 5.0 g/d of {L}-tryptophan has no adverse effects},\n\tvolume = {143},\n\tissn = {1541-6100},\n\tdoi = {10.3945/jn.112.173823},\n\tabstract = {Because of the frequent use of L-tryptophan (L-Trp) in dietary supplements, determination of the no-observed-adverse-effect-level is desirable for public health purposes. We therefore assessed the no-observed-adverse-effect-level for L-Trp and attempted to identify a surrogate biomarker for excess L-Trp in healthy humans. A randomized, double-blind, placebo-controlled, crossover intervention study was performed in 17 apparently healthy Japanese women aged 18-26 y with a BMI of ≈ 20 kg/m(2). The participants were randomly assigned to receive placebo (0 g/d) or 1.0, 2.0, 3.0, 4.0, or 5.0 g/d of L-Trp for 21 d each with a 5-wk washout period between trials. Food intake, body weight, general biomarkers in blood and urine, and amino acid composition in blood and urine were not affected by any dose of L-Trp. Administration of up to 5.0 g/d L-Trp had no effect on a profile of mood states category measurement. The urinary excretion of nicotinamide and its catabolites increased in proportion to the ingested amounts of L-Trp, indicating that participants could normally metabolize this amino acid. The urinary excretion of L-tryptophan metabolites, including kynurenine (Kyn), anthranilic acid, kynurenic acid, 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid, and quinolinic acid (QA), all of which are intermediates of the L-TRP→Kyn→QA pathway, was in proportion to L-Trp loading. The response of 3-HK was the most characteristic of these L-Trp metabolites. This finding suggests that the urinary excretion of 3-HK is a good surrogate biomarker for excess L-Trp ingestion.},\n\tlanguage = {eng},\n\tnumber = {6},\n\tjournal = {The Journal of Nutrition},\n\tauthor = {Hiratsuka, Chiaki and Fukuwatari, Tsutomu and Sano, Mitsue and Saito, Kuniaki and Sasaki, Satoshi and Shibata, Katsumi},\n\tmonth = jun,\n\tyear = {2013},\n\tpmid = {23616514},\n\tkeywords = {Adolescent, Adult, Biomarkers, Body Mass Index, Cross-Over Studies, Dietary Supplements, Double-Blind Method, Female, Humans, Kynurenic Acid, Kynurenine, Niacinamide, Placebos, Tryptophan, Young Adult, ortho-Aminobenzoates},\n\tpages = {859--866},\n}\n\n","author_short":["Hiratsuka, C.","Fukuwatari, T.","Sano, M.","Saito, K.","Sasaki, S.","Shibata, K."],"key":"hiratsuka_supplementing_2013","id":"hiratsuka_supplementing_2013","bibbaseid":"hiratsuka-fukuwatari-sano-saito-sasaki-shibata-supplementinghealthywomenwithupto50gdofltryptophanhasnoadverseeffects-2013","role":"author","urls":{},"keyword":["Adolescent","Adult","Biomarkers","Body Mass Index","Cross-Over Studies","Dietary Supplements","Double-Blind Method","Female","Humans","Kynurenic Acid","Kynurenine","Niacinamide","Placebos","Tryptophan","Young Adult","ortho-Aminobenzoates"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/tplas","dataSources":["YLgywGcXWx96vKKaB"],"keywords":["adolescent","adult","biomarkers","body mass index","cross-over studies","dietary supplements","double-blind method","female","humans","kynurenic acid","kynurenine","niacinamide","placebos","tryptophan","young adult","ortho-aminobenzoates"],"search_terms":["supplementing","healthy","women","tryptophan","adverse","effects","hiratsuka","fukuwatari","sano","saito","sasaki","shibata"],"title":"Supplementing healthy women with up to 5.0 g/d of L-tryptophan has no adverse effects","year":2013}